Neuroprotective Effects of Etidronate and 2,3,3-Trisphosphonate Against Glutamate-Induced Toxicity in PC12 Cells

Neurochemical Research

Volumn 41, Issue 4, 2016, Pages 844-854

  Li, Wen ^a   Cheong, Yuen Ki ^b   Wang, Hui ^a   Ren, Guogang ^b   Yang, Zhuo ^a  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

2,3,3 Trisphosphonate; Etidronate; Glutamate; Neuroprotection; PC12 cells

Indexed keywords

2,3,3 TRISPHOSPHONATE; CALCIUM; CASPASE 3; ETIDRONIC ACID; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; NEUROTOXIN; PHOSPHONIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FLOW CYTOMETRY; IN VITRO STUDY; MTT ASSAY; NEUROPROTECTION; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL NUCLEUS; CELL SURVIVAL; DRUG EFFECTS; INTRACELLULAR SPACE; METABOLISM; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; CALCIUM; CELL NUCLEUS; CELL SURVIVAL; ETIDRONIC ACID; GLUTAMIC ACID; INTRACELLULAR SPACE; NEUROPROTECTIVE AGENTS; ORGANOPHOSPHONATES; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84946771662     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1761-4     Document Type: Article

References (44)

1. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 78:157–169
2. Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80–100
3. Russell RG (2011) Bisphosphonates: the first 40 years. Bone 49:2–19
4. Russell RGG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209–257
5. Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38:375–388
6. Jung A, Bisaz S, Fleisch H (1973) The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res 11:269–280
7. Cheong Y-K, Duncanson P, Griffiths DV, Motevalli M (2010) The impact of ligand structure on the rhenium tricarbonyl complexes from tripodal pyridine-containing chelators. Nucl Med Biol 37:677–678
8. Zhou R, Deng J, Zhang M, Zhou HD, Wang YJ (2011) Association between bone mineral density and the risk of Alzheimer’s disease. J Alzheimers Dis 24:101–108
9. Lyell V, Henderson E, Devine M, Gregson C (2015) Assessment and management of fracture risk in patients with Parkinson’s disease. Age Ageing 44:34–41
10. Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ (2014) Bone health in Parkinson’s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 85:1159–1166
11. van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJJ (2012) Parkinson’s disease and osteoporosis. Age Ageing 42:156–162
12. Chang KH, Chung CJ, Lin CL, Sung FC, Wu TN, Kao CH (2014) Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordrecht) 36:967–975
13. Roos PM (2014) Osteoporosis in neurodegeneration. J Trace Elem Med Biol 28:418–421
14. Sato Y, Honda Y, Iwamoto J, Amano N (2013) Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease. J Musculoskelet Neuronal Interact 13:346–352
15. Li S, Liu B, Zhang L, Rong L (2014) Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. Bone 61:164–175
16. Xia WF, Jung JU, Shun C, Xiong S, Xiong L, Shi XM, Mei L, Xiong WC (2013) Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-l-cysteine. J Bone Miner Res 28:2122–2135
17. Lane RK, Hilsabeck T, Rea SL (2015) The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta 1847:1387–1400
18. Xu P, Xu J, Liu S, Ren G, Yang Z (2012) In vitro toxicity of nanosized copper particles in PC12 cells induced by oxidative stress. J Nanopart Res 14:1–9
19. Liu S, Han Y, Zhang T, Yang Z (2011) Protective effect of trifluoperazine on hydrogen peroxide-induced apoptosis in PC12 cells. Brain Res Bull 84:183–188
20. Xu L, Xu J, Liu S, Yang Z (2014) Induction of apoptosis by antimycin A in differentiated PC12 cell line. J Appl Toxicol 34:651–657
21. Han Y-g, Liu S-c, Zhang T, Yang Z (2011) Induction of apoptosis by melamine in differentiated PC12 cells. Cell Mol Neurobiol 31:65–71
22. Yang X, Wang Y, Luo J, Liu S, Yang Z (2011) Protective effects of YC-1 against glutamate induced PC12 cell apoptosis. Cell Mol Neurobiol 31:303–311
23. (2+) antagonism. Neurochem Int 70:10–21
24. Yan F, Wang M, Chen H, Su J, Wang X, Wang F, Xia L, Li Q (2011) Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. Eur J Pharmacol 652:23–32
25. Lin SS, Zhu B, Guo ZK, Huang GZ, Wang Z, Chen J, Wei XJ, Li Q (2014) Bone marrow mesenchymal stem cell-derived microvesicles protect rat pheochromocytoma PC12 cells from glutamate-induced injury via a PI3K/Akt dependent pathway. Neurochem Res 39:922–931
26. Liu X, Feng L, Yan M, Xu K, Yu Y, Zheng X (2010) Changes in mitochondrial dynamics during amyloid beta-induced PC12 cell apoptosis. Mol Cell Biochem 344:277–284
27. Liu S-b, Zhang N, Guo Y-y, Zhao R, Shi T-y, Feng S-f, Wang S-q, Yang Q, Li X-q, Wu Y-m, Ma L, Hou Y, Xiong L-z, Zhang W, Zhao M-g (2012) G-Protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. Journal of Neuroscience 32:4887–4900
28. Papapoulos SE (2008) Bisphosphonates: how do they work? Best Pract Res Clin Endocrinol Metab 22:831–847
29. Derenne S, Amiot M, Barille S, Collette M, Robillard N, Berthaud P, Harousseau JL, Bataille R (1999) Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. J Bone Miner Res 14:2048–2056
30. Paterson R (2002) Pamidronate next on list as potential cure for leishmaniasis. Lancet Infect Dis 2:515
31. Kunzmann V, Bauer E, Wilhelm M (1999) Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 340:737–738
32. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M (2000) Stimulation of gamma delta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384–392
33. Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP (2003) gamma delta T cells for immune therapy of patients with lymphoid malignancies. Blood 102:200–206
34. Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, Cicero G, Roberts A, Buccheri S, D’Asaro M, Gebbia N, Salerno A, Eberl M, Hayday AC (2007) Targeting human gamma delta T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 67:7450–7457
35. Oldfield E (2010) Targeting isoprenoid biosynthesis for drug discovery: bench to bedside. Acc Chem Res 43:1216–1226
36. Rudy CC, Hunsberger HC, Weitzner DS, Reed MN (2015) The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer’s disease. Aging Dis 6:131–148
37. Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgrafe K, Mandelkow EM, Holtzman DM (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211:387–393
38. Li N, Liu B, Dluzen DE, Jin Y (2007) Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol 111:458–463
39. (2+) influx. Neurotoxicology 33:59–69
40. Sun R, Wang K, Wu D, Li X, Ou Y (2012) Original article Protective effect of paeoniflorin against glutamate-induced neurotoxicity in PC12 cells via Bcl-2/Bax signal pathway. Folia Neuropathol 3:270–276
41. Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39–46
42. Pi R, Li W, Lee NT, Chan HH, Pu Y, Chan LN, Sucher NJ, Chang DC, Li M, Han Y (2004) Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J Neurochem 91:1219–1230
43. Hausenloy D (2003) The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35:339–341
44. 2+-induced oxidative stress in brain mitochondria treated with the respiratory chain inhibitor rotenone. FEBS Lett 543:179–183